Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non–small-cell lung cancer: a case report-Reference-Cited by-同舟云学术

Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non–small-cell lung cancer: a case report

Published:2021-08-20 Issue:1 Volume:33 Page:e784-e788
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Liu Yunpeng,Gao Zhiru,Zhang Chengbin,Liu Xing,Liu Zihao,Lin Xingyu,Qian Benxin,Jin Fukang,Shao Guoguang,Yang Zhiguang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference20 articles.

1. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2020

2. Lung cancer 2020: epidemiology, etiology, and prevention.;Bade;Clin Chest Med,2020

3. Adjuvant chemotherapy of completely resected early stage non-small cell lung cancer (NSCLC).;Liang;Transl Lung Cancer Res,2013

4. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.;Gubin;Nature,2014

5. Neoadjuvant PD-1 blockade in resectable lung cancer.;Forde;N Engl J Med,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective neoadjuvant immunotherapy and chemotherapy in stage IIIA adenosquamous carcinoma of the lung with a complete response and surgical success: A case report;Oncology Letters;2024-05-14

2. Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer;Lung Cancer;2023-12

3. Major pathological remissions in a patient with stage IIIA nonsmall cell lung cancer after neoadjuvant tislelizumab combined with chemotherapy: a case report and literature review;Anti-Cancer Drugs;2023-01-04